Latest Content

Adcetris Plus Revlimid and Rituxan Continues to Improve Relapsed/Refractory Diffuse Large B-Cell Lymphoma Results

September 11th 2024, 1:00pm

By Kristi Rosa

Article

Adcetris plus Revlimid/Rituxan significantly improved outcomes versus Revlimid/Rituxan alone in relapsed/refractory lymphoma.

First-Line Rybrevant Plus Lazcluze Shows Trend Toward Overall Survival in EGFR-Positive NSCLC

September 10th 2024, 9:00pm

By Ashley Chan

Article

Rybrevant plus Lazcluze, compared with Tagrisso, showed a trend towards favorable overall survival in EGFR-positive advanced non-small cell lung cancer.

‘Never Give Up’: Treatment Breakthroughs Arrive for SCLC

September 10th 2024, 7:00pm

By Alex Biese

Article

With pivotal trial results and an approval from the FDA, the landscape is changing for patients with small cell lung cancer.

Yes, You Can Donate Many Unused Cancer Drugs

September 10th 2024, 5:00pm

By Martha Carlson

Article

A patient with metastatic breast cancer confronts financial toxicity and finds a little glimmer of hope through donating cancer drugs.

Pros and Cons of Surgery Approaches in Gynecologic Cancers

September 10th 2024, 3:00pm

By Ashley Chan

Article

Surgery for gynecologic cancers is a common form of treatment, but each surgical approach has its advantages and disadvantages for patients.

Xtandi Offers Small Benefits Over Zytiga in Advanced Prostate Cancer

September 10th 2024, 1:22pm

By Alex Biese

Article

Researchers have compared Xtandi and Zytiga head-to-head in the treatment of metastatic castration-resistant prostate cancer.

Understanding Molecular Classifications of Gynecologic Cancers

September 9th 2024, 9:00pm

By Brielle Benyon

Article

After being diagnosed with a type of gynecologic cancer, it is essential for patients to understand the molecular makeup of their disease.

Making Dynamic Decisions as AYAs During the Cancer Treatment Process

September 9th 2024, 7:49pm

By Ashley Chan

Article

During the cancer treatment process, it's important for adolescents and young adults to balance independence while seeking support from loved ones.

Self-Healing Through Journaling and Faith During Colon Cancer

September 9th 2024, 5:00pm

By Carla Deschamps

Article

Through journaling and connecting with my faith, I was able to embrace everything I was thinking and feeling during colon cancer.

Patient Characteristics Guide Decision Making for JAK Inhibitors in Myelofibrosis

September 9th 2024, 3:00pm

By Brielle Benyon

Video

Spleen size, blood counts and symptom burden are some of the factors cancer teams take into account when selecting which of the four JAK inhibitors to treat patient with myelofibrosis.

Lazcluze, Rybrevant Approval a ‘Big Deal’ for EGFR-Mutant NSCLC

September 9th 2024, 1:00pm

By Brielle Benyon

Article

The recent FDA approval of Lazcluze plus Rybrevant for EGFR-mutant non-small cell lung cancer is a “big deal” for patients, an oncologist said.

FDA OKed New Drug Application for Novel Glioblastoma Treatment

September 8th 2024, 5:00pm

By Ashley Chan

Article

The novel glioblastoma treatment, APTN-101, had its new drug application accepted by the FDA.

A Poem in Honor of My Niece Who Had Breast Cancer

September 7th 2024, 6:00pm

By Margarette Evans

Article

I wrote this poem in honor of my niece who had breast cancer, who was determined to live out the rest of her life giving her loved ones hope and strength.

Compassionate Advocate in Cancer Care

September 7th 2024, 2:00pm

By Tina M. Mason, PhD, APRN, AOCN, AOCNS, FCNS

Article

An extraordinary oncology nurse guided cancer care for a man who was legally blind.

My Worries About Being Old as an MDS Survivor

September 6th 2024, 5:00pm

By Jane Biehl Ph.D.

Article

Having myelodysplastic syndromes has taught me to cherish every day and to pursue the things that matter to me, like publishing a book I’ve been writing.